A Phase 1 study of gefitinib combined with durvalumab in EGFR TKI-naive patients with EGFR mutation-positive locally advanced/metastatic non-small-cell lung cancer

British Journal of Cancer, Published online: 05 October 2020; doi:10.1038/s41416-020-01099-7A Phase 1 study of gefitinib combined with durvalumab in EGFR TKI-naive patients with EGFR mutation-positive locally advanced/metastatic non-small-cell lung cancer

http://feeds.nature.com/~r/bjc/rss/current/~3/71LTsd5julI/s41416-020-01099-7

Source: British Journal of Cancer - October 4, 2020 Category: Cancer & Oncology Authors: Benjamin C. Creelan Tammie C. Yeh Sang-We Kim Naoyuki Nogami Dong-Wan Kim Laura Q. M. Chow Shintaro Kanda Rosemary Taylor Weifeng Tang Mei Tang Helen K. Angell Martine P. Roudier Marcelo Marotti Don L. Gibbons Source Type: research